Pharmalgen for the treatment of bee and wasp venom allergy

  • Technology appraisal guidance
  • TA246
  • Published: 
Download guidance (PDF)

1 Guidance

1.1 Pharmalgen is recommended as an option for the treatment of IgE-mediated bee and wasp venom allergy in people who have had:

  • a severe systemic reaction to bee or wasp venom, or

  • a moderate systemic reaction to bee or wasp venom and who have one or more of the following: a raised baseline serum tryptase, a high risk of future stings or anxiety about future stings.

1.2 Treatment with Pharmalgen should be initiated and monitored in a specialist centre experienced in venom immunotherapy.